What it's for (Indications)
- Polyacrylic acid, commonly found in ophthalmic formulations such as gels or artificial tears (e.
- g.
- , Visol Gel), is indicated for the symptomatic relief of dry eye conditions.
- This includes alleviating discomfort, burning, irritation, and foreign body sensation associated with insufficient tear production or exposure to environmental factors that contribute to ocular dryness.
- Its application aims to stabilize the tear film, reduce tear evaporation, and provide sustained lubrication to the ocular surface, thereby improving patient comfort and protecting the corneal and conjunctival epithelia from damage due to desiccation.
- It is also utilized in situations requiring enhanced ocular surface lubrication, such as after ophthalmic procedures or prolonged visual tasks, ensuring adequate hydration and minimizing ocular strain.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | For ophthalmic use, the typical dosage of polyacrylic acid gel is one drop or a small amount (approximately a grain of rice size) instilled into the conjunctival sac of the affected eye(s) three to four times daily, or as directed by a healthcare professional. The frequency of application may be adjusted based on the severity of the dry eye symptoms and individual patient response. It is crucial for patients to wash their hands thoroughly before application and to avoid touching the tip of the dispenser to any surface, including the eye or fingers, to prevent contamination. If other ophthalmic medications are being used, a waiting period of at least 5-10 minutes between applications is generally recommended, with polyacrylic acid gel typically applied last due to its viscous nature, which can prolong contact time and potentially interfere with the absorption of other topical medications. |
Safety & Warnings
Common Side Effects
- While generally well-tolerated, polyacrylic acid ophthalmic preparations may cause some transient side effects.
- The most commonly reported adverse reactions include temporary blurred vision immediately following instillation, which usually resolves within a few minutes, and mild ocular irritation or stinging.
- Other less frequent side effects may include a foreign body sensation, eye discomfort, or watery eyes.
- In rare instances, individuals may experience allergic reactions, manifesting as itching, redness, swelling of the eyelids, or a more generalized hypersensitivity response; should any severe or persistent irritation occur, patients are advised to discontinue use and consult their ophthalmologist.
- Patients should be counselled that these effects are typically mild and transient, but any worsening or persistent symptoms warrant medical review.
Serious Warnings
- Black Box Warning: ## Serious Warnings Regarding Polyacrylic Acid Ophthalmic Preparations Polyacrylic acid ophthalmic preparations, commonly used as artificial tears or lubricating gels for dry eye, do not typically carry a specific FDA-mandated Black Box Warning. However, healthcare professionals and patients must be aware of serious warnings and precautions essential for safe and effective use. While severe adverse events are uncommon, the potential for ocular irritation, allergic reactions, and the risk of contamination necessitates careful attention. Persistent or worsening ocular discomfort, redness, pain, or changes in vision during treatment should be considered a serious indicator for immediate discontinuation and ophthalmological evaluation, as these symptoms could mask underlying ocular pathologies or represent an unaddressed adverse reaction to the product. Furthermore, improper handling leading to microbial contamination of the product can result in severe ocular infections, potentially leading to corneal ulcers, vision loss, or requiring surgical intervention. Patients must be rigorously educated on sterile handling practices and the importance of discarding contaminated or expired products to mitigate these significant risks to ocular health and integrity.
- For external ophthalmic use only.
- It is imperative to instruct patients not to ingest this product.
- To prevent contamination, patients must not touch the tip of the dispenser to the eye or any other surface.
- If the solution changes color or becomes cloudy, it should be discarded.
- Patients experiencing persistent eye pain, redness, irritation, or changes in vision, or if the dry eye condition worsens or persists for more than 72 hours despite use, should discontinue the medication and consult a healthcare professional immediately.
- Temporary blurred vision may occur after instillation; patients should be advised to exercise caution when driving or operating machinery until their vision clears.
- Contact lens wearers should remove their lenses before applying the gel and wait at least 15 minutes before reinserting them, as the gel may coat the lenses and cause discomfort or clouding.
How it Works (Mechanism of Action)
Polyacrylic acid, specifically carbomer, functions as a highly effective ophthalmic lubricant and tear film stabilizer. Its mechanism of action relies on its polymeric structure, which consists of high molecular weight, cross-linked acrylic acid polymers. Upon instillation into the eye, polyacrylic acid rapidly absorbs water from the tear film and swells, forming a clear, viscous, and mucoadhesive gel-like layer over the ocular surface. This layer mimics the natural mucin layer of the tear film, providing enhanced lubrication and significantly increasing the tear film's retention time on the eye. By prolonging the contact time of the aqueous phase of the tears and reducing tear evaporation, polyacrylic acid effectively alleviates the symptoms of dry eye, protects the corneal and conjunctival epithelia from desiccation, and improves overall ocular comfort. Its high viscosity provides a long-lasting protective barrier without causing significant visual interference once settled.
Commercial Brands (Alternatives)
No other brands found for this formula.